BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15244231)

  • 1. Relationship of maternal autoimmune response to clinical manifestations in children with congenital complete heart block.
    Eronen M; Miettinen A; Walle TK; Chan EK; Julkunen H
    Acta Paediatr; 2004 Jun; 93(6):803-9. PubMed ID: 15244231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significantly increased maternal and fetal IgG autoantibody levels to 52 kD Ro (SS-A) and La(SS-B) in complete congenital heart block.
    Dörner T; Chaoui R; Feist E; Göldner B; Yamamoto K; Hiepe F
    J Autoimmun; 1995 Oct; 8(5):675-84. PubMed ID: 8579723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune response in mothers of children with congenital and postnatally diagnosed isolated heart block: a population based study.
    Julkunen H; Miettinen A; Walle TK; Chan EK; Eronen M
    J Rheumatol; 2004 Jan; 31(1):183-9. PubMed ID: 14705240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies.
    Buyon JP; Winchester RJ; Slade SG; Arnett F; Copel J; Friedman D; Lockshin MD
    Arthritis Rheum; 1993 Sep; 36(9):1263-73. PubMed ID: 8216420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal autoantibodies and congenital heart block: no evidence for the existence of a unique heart block-associated anti-Ro/SS-A autoantibody profile.
    Meilof JF; Frohn-Mulder IM; Stewart PA; Szatmari A; Hess J; Veldhoven CH; Smeenk RJ; Swaak AJ
    Lupus; 1993 Aug; 2(4):239-46. PubMed ID: 7505695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal predictive factors for fetal congenital heart block in pregnant mothers positive for anti-SS-A antibodies.
    Tsuboi H; Sumida T; Noma H; Yamagishi K; Anami A; Fukushima K; Horigome H; Maeno Y; Kishimoto M; Takasaki Y; Nakayama M; Waguri M; Sago H; Murashima A
    Mod Rheumatol; 2016 Jul; 26(4):569-75. PubMed ID: 26457409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Ro/SSA-p200 antibodies in the prediction of congenital heart block. An Italian multicentre cross-sectional study on behalf of the 'Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) Group'.
    Scarsi M; Radice A; Pregnolato F; Ramoni V; Grava C; Bianchi L; Gerosa M; Mosca M; Ghirardello A; Tani C; Motta M; Quinzanini M; Tincani A; Ruffatti A; Migliorini P; Doria A; Meroni PL; Brucato A
    Clin Exp Rheumatol; 2014; 32(6):848-54. PubMed ID: 25327946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated congenital heart block. Long-term outcome of mothers and characterization of the immune response to SS-A/Ro and to SS-B/La.
    Julkunen H; Kurki P; Kaaja R; Heikkilä R; Immonen I; Chan EK; Wallgren E; Friman C
    Arthritis Rheum; 1993 Nov; 36(11):1588-98. PubMed ID: 8240435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry.
    Buyon JP; Hiebert R; Copel J; Craft J; Friedman D; Katholi M; Lee LA; Provost TT; Reichlin M; Rider L; Rupel A; Saleeb S; Weston WL; Skovron ML
    J Am Coll Cardiol; 1998 Jun; 31(7):1658-66. PubMed ID: 9626848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune congenital heart block and primary Sjögren's syndrome: characterisation and outcomes of 49 cases.
    Brito-Zerón P; Pasoto SG; Robles-Marhuenda A; Mandl T; Vissink A; Armagan B; Praprotnik S; Nocturne G; Sebastian A; Fernandes Moça Trevisani V; Retamozo S; Acar-Denizli N; Wiland P; Sisó-Almirall A; Bootsma H; Mariette X; Ramos-Casals M; Kostov B;
    Clin Exp Rheumatol; 2020; 38 Suppl 126(4):95-102. PubMed ID: 33025893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune-mediated congenital heart block (CHB): identifying and counseling patients at risk for having children with CHB.
    Julkunen H; Kaaja R; Siren MK; Mack C; McCready S; Holthöfer H; Kurki P; Maddison P
    Semin Arthritis Rheum; 1998 Oct; 28(2):97-106. PubMed ID: 9806370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects.
    Clancy RM; Buyon JP; Ikeda K; Nozawa K; Argyle DA; Friedman DM; Chan EK
    Arthritis Rheum; 2005 Oct; 52(10):3079-86. PubMed ID: 16200587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High maternal expression of SIGLEC1 on monocytes as a surrogate marker of a type I interferon signature is a risk factor for the development of autoimmune congenital heart block.
    Lisney AR; Szelinski F; Reiter K; Burmester GR; Rose T; Dörner T
    Ann Rheum Dis; 2017 Aug; 76(8):1476-1480. PubMed ID: 28501799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
    Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
    Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital heart block in neonatal lupus: the pediatric cardiologist's perspective.
    Friedman DM; Rupel A; Glickstein J; Buyon JP
    Indian J Pediatr; 2002 Jun; 69(6):517-22. PubMed ID: 12139139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive value of anti-SS-A antibodies titration in pregnant women with fetal congenital heart block.
    Anami A; Fukushima K; Takasaki Y; Sumida T; Waguri M; Wake N; Murashima A
    Mod Rheumatol; 2013 Jul; 23(4):653-8. PubMed ID: 22760476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of mothers of children with complete congenital heart block.
    Press J; Uziel Y; Laxer RM; Luy L; Hamilton RM; Silverman ED
    Am J Med; 1996 Mar; 100(3):328-32. PubMed ID: 8629679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responses to SS-A 52-kDa and 60-kDa proteins and to SS-B 50-kDa protein in mothers of infants with neonatal lupus erythematosus.
    Yukiko N
    Br J Dermatol; 2000 May; 142(5):908-12. PubMed ID: 10809847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry.
    Neiman AR; Lee LA; Weston WL; Buyon JP
    J Pediatr; 2000 Nov; 137(5):674-80. PubMed ID: 11060534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of HLA in congenital heart block: susceptibility alleles in mothers.
    Sirén MK; Julkunen H; Kaaja R; Kurki P; Koskimies S
    Lupus; 1999; 8(1):52-9. PubMed ID: 10025599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.